Close
0
You have no items in your order cart.
Search
Filters

Vaccines

View as Grid List
Sort by
Display per page

Biosuis Salm Emulsion for Injection Pigs - 50ml

158054
For the passive immunisation of piglets by the active immunisation of pregnant gilts and sows in order to induce colostral antibodies against strains of Salmonella enterica subsp. enterica serovar Derby, S. enterica subsp. enterica serovar Infantis and S. enterica subsp. enterica serovar Typhimurium. In suckling piglets passive immunisation leads to a decrease in colonisation of inner organs (ileo-caecal lymph nodes, ileal wall and colon wall) by the above Salmonella serovars. Onset of immunity: passive protection commences from the start of colostrum intake. Duration of immunity: in naturally suckled piglets protection will persist for 30 days (in piglets weaned at 21 days of age). Dosage, application and vaccination scheme Vaccination dose 1 ml, intramuscularly behind the ear. Primary vaccination: The primary vaccination consists of two doses and is administered from 10 months of age: The first dose is administered 4 weeks before the expected parturition and the second dose 2 weeks later. Revaccination: In subsequent gestation periods administer one dose of the vaccine 2 weeks before each expected parturition.

Blackleg Vaccine - 50ml

100330
For the active immunisation of sheep and cattle to reduce mortality and clinical signs of blackleg disease caused by clostridium chauvoei. Active ingredient: Clostridium chauvoei

Bovalto Respi 3 - 10ml

136304
For active immunisation of cattle in the absence of maternally derived antibodies against: • parainfluenza 3 virus, to reduce virus excretion due to infection • bovine respiratory syncytial virus, to reduce virus excretion due to infection • Mannheimia haemolytica serotype A1, to reduce clinical signs and lung lesions. Onset of immunity (demonstrated by challenge): • 3 weeks after primary vaccination • Duration of immunity (demonstrated by challenge): 6 months after primary vaccination Dosage & Administration 2 ml to be administered subcutaneously. Primary vaccination • Calves can be vaccinated from 2 weeks of age. • Calves from non-immune dams: 2 injections 3 weeks apart from 2 weeks of age Where the immune status of the dam is unknown, the vaccine scheme should be adapted at the discretion of the veterinarian. Revaccination Administer a single dose 6 months after completion of the primary vaccination scheme. Withdrawals: Zero day

Bovalto Respi 3 - 50ml

136314
For active immunisation of cattle in the absence of maternally derived antibodies against: • parainfluenza 3 virus, to reduce virus excretion due to infection • bovine respiratory syncytial virus, to reduce virus excretion due to infection • Mannheimia haemolytica serotype A1, to reduce clinical signs and lung lesions. Onset of immunity (demonstrated by challenge): • 3 weeks after primary vaccination • Duration of immunity (demonstrated by challenge): 6 months after primary vaccination Dosage & Administration 2 ml to be administered subcutaneously. Primary vaccination • Calves can be vaccinated from 2 weeks of age. • Calves from non-immune dams: 2 injections 3 weeks apart from 2 weeks of age Where the immune status of the dam is unknown, the vaccine scheme should be adapted at the discretion of the veterinarian. Revaccination Administer a single dose 6 months after completion of the primary vaccination scheme. Withdrawals: Zero day

Bovalto Respi 4 - 10ml

136324
For active immunisation of cattle in the absence of maternally derived antibodies against: • parainfluenza 3 virus, to reduce virus excretion due to infection • bovine respiratory syncytial virus, to reduce virus excretion due to infection • bovine viral diarrhoea virus, to reduce virus excretion due to infection • Mannheimia haemolytica serotype A1, to reduce clinical signs and lung lesions. Onset of immunity (demonstrated by challenge): • 3 weeks after primary vaccination • Duration of immunity (demonstrated by challenge): 6 months after primary vaccination Dosage & Administration 2 ml to be administered subcutaneously. Primary vaccination • Calves can be vaccinated from 2 weeks of age. • Calves from non-immune dams: 2 injections 3 weeks apart from 2 weeks of age Where the immune status of the dam is unknown, the vaccine scheme should be adapted at the discretion of the veterinarian. Revaccination Administer a single dose 6 months after completion of the primary vaccination scheme. Withdrawals: Zero days

Bovalto Respi 4 - 50ml

136334
For active immunisation of cattle in the absence of maternally derived antibodies against: • parainfluenza 3 virus, to reduce virus excretion due to infection • bovine respiratory syncytial virus, to reduce virus excretion due to infection • bovine viral diarrhoea virus, to reduce virus excretion due to infection • Mannheimia haemolytica serotype A1, to reduce clinical signs and lung lesions. Onset of immunity (demonstrated by challenge): • 3 weeks after primary vaccination • Duration of immunity (demonstrated by challenge): 6 months after primary vaccination Dosage & Administration 2 ml to be administered subcutaneously. Primary vaccination • Calves can be vaccinated from 2 weeks of age. • Calves from non-immune dams: 2 injections 3 weeks apart from 2 weeks of age Where the immune status of the dam is unknown, the vaccine scheme should be adapted at the discretion of the veterinarian. Revaccination Administer a single dose 6 months after completion of the primary vaccination scheme. Withdrawals: Zero days

Bovalto Respi Intranasal Spray - 10ml

148384
For the active immunisation of calves from the age of 10days against bovine respiratory syncytial virus (BRSV) and bovine parainfluenza 3 virus (PI3V), to reduce the quality and duration of nasal excretion of both viruses. Onset of immunity - 10days after vaccine Duration of immunity - 12 weeks after vaccination Dosage & Administration Administer one dose (2ml) of the reconstituted vaccine intranasally (1ml of the vaccine per nostril) to calves from 10days of age using an intranasal applicator. Withdrawals: Zero days

Bovela BVD - 100ml

140934
For active immunisation of cattle from 3 months of age to reduce hyperthermia and to minimise the reduction of leukocyte count caused by bovine viral diarrhoea virus (BVDV-1 and BVDV-2), and to reduce virus shedding and viraemia caused by BVDV-2. For active immunisation of cattle against BVDV-1 and BVDV-2, to prevent the birth of persistently infected calves caused by transplacental infection. Onset of immunity: 3 weeks after immunisation. Duration of immunity: 1 year. Dosage & Administration Primary vaccination: After reconstitution, administer one dose (2 ml) of the vaccine by intramuscular (IM) injection. It is recommended to vaccinate cattle at least 3 weeks before insemination/mating to provide foetal protection from the first day of conception. Animals which are vaccinated later than 3 weeks before gestation or during the early gestation may not be protected against foetal infection. This should be considered in case of herd vaccination. Recomended re-vaccination programme: Revaccination is recommended after 1 year. 12 months after primary vaccination most studied animals still had antibody titres at plateau while some animals had lower titres. Withdrawals: Zero days

Bovela BVD - 10ml

131824
For active immunisation of cattle from 3 months of age to reduce hyperthermia and to minimise the reduction of leukocyte count caused by bovine viral diarrhoea virus (BVDV-1 and BVDV-2), and to reduce virus shedding and viraemia caused by BVDV-2. For active immunisation of cattle against BVDV-1 and BVDV-2, to prevent the birth of persistently infected calves caused by transplacental infection. Onset of immunity: 3 weeks after immunisation. Duration of immunity: 1 year. Dosage & Administration Primary vaccination: After reconstitution, administer one dose (2 ml) of the vaccine by intramuscular (IM) injection. It is recommended to vaccinate cattle at least 3 weeks before insemination/mating to provide foetal protection from the first day of conception. Animals which are vaccinated later than 3 weeks before gestation or during the early gestation may not be protected against foetal infection. This should be considered in case of herd vaccination. Recomended re-vaccination programme: Revaccination is recommended after 1 year. 12 months after primary vaccination most studied animals still had antibody titres at plateau while some animals had lower titres. Withdrawals: Zero days

Bovela BVD - 50ml

131834
For active immunisation of cattle from 3 months of age to reduce hyperthermia and to minimise the reduction of leukocyte count caused by bovine viral diarrhoea virus (BVDV-1 and BVDV-2), and to reduce virus shedding and viraemia caused by BVDV-2. For active immunisation of cattle against BVDV-1 and BVDV-2, to prevent the birth of persistently infected calves caused by transplacental infection. Onset of immunity: 3 weeks after immunisation. Duration of immunity: 1 year. Dosage & Administration Primary vaccination: After reconstitution, administer one dose (2 ml) of the vaccine by intramuscular (IM) injection. It is recommended to vaccinate cattle at least 3 weeks before insemination/mating to provide foetal protection from the first day of conception. Animals which are vaccinated later than 3 weeks before gestation or during the early gestation may not be protected against foetal infection. This should be considered in case of herd vaccination. Recomended re-vaccination programme: Revaccination is recommended after 1 year. 12 months after primary vaccination most studied animals still had antibody titres at plateau while some animals had lower titres. Withdrawals: Zero days

Bovigen - 15ml

136944
For the active immunisation of pregnant cows and heifers to raise antibodies against E. coli adhesion F5 (K 99) antigen, rotavirus and coronavirus. When calves are fed colostrum from vaccinated cows during the first week of life, these antibodies have been demonstrated to reduce the severity of diarrhoea caused by bovine rotavirus, bovine coronavirus and enteropathogenic E. coli F5 (K99) and to reduce the shedding of virus by calves infected with bovine rotavirus or bovine coronavirus. Onset of immunity: Passive immunity commences with colostrum feeding and is dependent on calves receiving sufficient colostrum after birth. Dosage & Administration One dose: 3 ml intramuscular One dose in the course of each pregnancy, given in the 12 - 3 week period before calving is expected.

Bovigen - 90ml

136954
For the active immunisation of pregnant cows and heifers to raise antibodies against E. coli adhesion F5 (K 99) antigen, rotavirus and coronavirus. When calves are fed colostrum from vaccinated cows during the first week of life, these antibodies have been demonstrated to reduce the severity of diarrhoea caused by bovine rotavirus, bovine coronavirus and enteropathogenic E. coli F5 (K99) and to reduce the shedding of virus by calves infected with bovine rotavirus or bovine coronavirus. Onset of immunity: Passive immunity commences with colostrum feeding and is dependent on calves receiving sufficient colostrum after birth. Dosage & Administration One dose: 3 ml intramuscular One dose in the course of each pregnancy, given in the 12 - 3 week period before calving is expected.